FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/17/2024
Back to search
Official data from USPTO
QUENREGNA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
11/17/2024
Trademark type
Word
Nice classes
5
Filing date
02/08/2023
Registration date
04/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/23/2024
Last transaction
04/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
BE
Examiner
HA, PAULINE T.
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Estetra SRL
Representatives
Clifford D Hyra Fresh IP PLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disorders; medicinal preparations and substances for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disorders; medicines for human use for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disorders; biochemical medicines for human use for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disorders; pharmaceutical preparations and substances in the field of gynecology and female health for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disorders; estrogen preparations for therapeutic purposes; pharmaceutical preparations containing estrogen; pharmaceutical preparations for the treatment of female hormonal dysfunction; pharmaceutical preparations for use in hormone replacement therapy; pharmaceutical preparations for the treatment of menopausal symptomsconditions and disorders
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/24/2024
FIMP
FINAL DISPOSITION PROCESSED
10/24/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/24/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/23/2024
GPNX
NOTIFICATION PROCESSED BY IB
02/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2024
PUBO
PUBLISHED FOR OPPOSITION
02/06/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/28/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/17/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/17/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/17/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/28/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/28/2023
RFNP
REFUSAL PROCESSED BY IB
12/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/14/2023
RFRR
REFUSAL PROCESSED BY MPU
11/14/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/14/2023
CNRT
NON-FINAL ACTION WRITTEN
11/13/2023
DOCK
ASSIGNED TO EXAMINER
11/07/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/17/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/09/2023
Continuous trademark protection
Get notified about every new filing that threatens QUENREGNA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.